共 50 条
- [31] First clinical experience with the tacrolimus-eluting Janus Carbostent in de novo coronary arteries: The Jupiter I study AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (6A): : 60L - 60L
- [32] Comparison of Dual Drug-Eluting Cilotax Stent and Paclitaxel-Eluting Taxus Liberte Stent in Native Coronary Artery Lesions AMERICAN JOURNAL OF CARDIOLOGY, 2011, 107 (07): : 990 - 994
- [33] Comparison of Everolimus-Eluting and Paclitaxel-Eluting Coronary Stents in Patients Undergoing Multilesion and Multivessel Intervention The SPIRIT III (A Clinical Evaluation of the Investigational Device XIENCE V Everolimus Eluting Coronary Stent System [EECSS] in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) and SPIRIT IV (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) Randomized Trials JACC-CARDIOVASCULAR INTERVENTIONS, 2010, 3 (12) : 1229 - 1239
- [34] Randomized comparison of the efficacy of sirolimus-eluting stent versus paclitaxel-eluting stent in the treatment of long native coronary lesions: LONG-DES-II study AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (8A): : 142M - 142M
- [37] ABSORB trial: twelve months results of clinical evaluation of the Bioabsorbable Everolimus-Eluting coronary Stent system in the treatment of patients with de novo native coronary artery lesions AMERICAN JOURNAL OF CARDIOLOGY, 2007, 100 (8A): : 36L - 37L
- [39] Drug-eluting stents for the treatment of small coronary artery: A comparison of serial angiographic follow-up with sirolimus, paclitaxel, zotarolimus and tacrolimus-eluting stent: Multicenter registry in Asia AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (8A): : 127M - 128M